Rate-controlled DDS – Concepts & Types MCQs With Answer

Introduction: Rate-controlled drug delivery systems (DDS) are engineered to release therapeutic agents at predetermined rates, durations, and target sites, improving efficacy and safety. This blog focuses on core concepts and common types of rate-controlled DDS relevant to M.Pharm students, including diffusion-, erosion-, osmotic-, and swelling-controlled systems, as well as reservoir and matrix designs. Emphasis is placed on mechanisms (diffusion, dissolution, biodegradation), mathematical descriptions (zero-order, first-order, Higuchi, Korsmeyer–Peppas), design considerations (polymer selection, membrane properties, drug solubility), and performance evaluation (in vitro models and IVIVC). The MCQs provided will test both conceptual understanding and applied design reasoning for advanced pharmaceutical development.

Q1. Which mechanism primarily governs drug release from a non-degradable matrix where the drug is uniformly dispersed in a polymer?

• Polymer erosion-driven release
• Diffusion through the polymer matrix
• Osmotic pressure-driven expulsion
• Ion-exchange-mediated release

Correct Answer: Diffusion through the polymer matrix

Q2. Which release kinetics corresponds to a constant amount of drug released per unit time, often desired in rate-controlled systems?

• First-order kinetics
• Higuchi square-root kinetics
• Zero-order kinetics
• Michaelis–Menten kinetics

Correct Answer: Zero-order kinetics

Q3. The Higuchi model is best applied to systems where drug release is governed by which of the following assumptions?

• Sink conditions, initial drug uniformly dispersed, and diffusion-controlled release
• Membrane rupture followed by burst release
• Polymer degradation is the rate-limiting step
• Osmotic pumping through a semipermeable membrane

Correct Answer: Sink conditions, initial drug uniformly dispersed, and diffusion-controlled release

Q4. In a reservoir-type transdermal patch, which component primarily controls the steady-state flux of drug through the membrane?

• The adhesive layer
• The drug reservoir particle size
• The rate-controlling membrane permeability and thickness
• The backing layer color

Correct Answer: The rate-controlling membrane permeability and thickness

Q5. Which of the following best describes an osmotic pump (e.g., OROS) mechanism for controlled release?

• Drug diffuses out by erosion of a biodegradable matrix
• Water influx generates osmotic pressure that drives drug release through an orifice
• Drug is released by ion-exchange resin displacement
• Drug release depends solely on temperature-induced polymer melting

Correct Answer: Water influx generates osmotic pressure that drives drug release through an orifice

Q6. Which parameter is most critical to maintain sink conditions during in vitro release testing of poorly soluble drugs in rate-controlled systems?

• Low agitation speed
• Large volume of dissolution medium or solubilizing agents
• Using a small surface area of the dosage form
• High temperature above 50°C

Correct Answer: Large volume of dissolution medium or solubilizing agents

Q7. For a polymeric system showing anomalous (non-Fickian) release, which combined mechanisms are typically responsible?

• Pure diffusion only
• Pure erosion only
• Simultaneous diffusion and polymer relaxation/erosion
• Osmosis and ion-exchange exclusively

Correct Answer: Simultaneous diffusion and polymer relaxation/erosion

Q8. Which mathematical model is commonly used to interpret release from swellable polymer systems and gives the release exponent (n) for mechanism elucidation?

• Higuchi model
• Korsmeyer–Peppas model
• First-order exponential model
• Langmuir isotherm

Correct Answer: Korsmeyer–Peppas model

Q9. In a core-shell reservoir implant with a rate-controlling polymer shell, which design change would decrease drug release rate most effectively?

• Increase drug concentration in the core
• Reduce shell thickness
• Increase shell thickness or use a less permeable polymer
• Introduce micropores into the shell

Correct Answer: Increase shell thickness or use a less permeable polymer

Q10. Which factor does NOT significantly influence diffusion-controlled release from a matrix system?

• Drug solubility in polymer
• Diffusion coefficient of drug in the polymer
• Ambient humidity if matrix is non-hygroscopic and non-swellable
• Partition coefficient between polymer and external medium

Correct Answer: Ambient humidity if matrix is non-hygroscopic and non-swellable

Q11. Ion-exchange resins in rate-controlled DDS typically modulate release by which mechanism?

• Diffusion through a hydrophobic membrane
• Exchange of drug ions with counter-ions in the gastrointestinal fluids
• Osmotically driven extrusion of drug
• Enzymatic degradation of the resin

Correct Answer: Exchange of drug ions with counter-ions in the gastrointestinal fluids

Q12. Which polymer property is most important when designing a biodegradable implant intended for erosion-controlled release over months?

• Glass transition temperature only
• Polymer molecular weight and hydrolytic degradation rate
• Color and opacity of polymer
• Electrical conductivity

Correct Answer: Polymer molecular weight and hydrolytic degradation rate

Q13. Lag time in transdermal or membrane-controlled systems is primarily determined by which factor?

• Initial drug concentration alone
• Time required for drug to establish steady-state concentration gradient across the barrier
• Total dose loaded into the reservoir regardless of membrane
• pH of the external medium only

Correct Answer: Time required for drug to establish steady-state concentration gradient across the barrier

Q14. Which test parameter is crucial to establish an in vitro–in vivo correlation (IVIVC) for a rate-controlled oral dosage form?

• Similarity of hydrodynamics and media composition to the physiological environment
• Testing at only one agitation speed
• Ignoring sink conditions to speed up testing
• Using arbitrary temperatures unrelated to physiological range

Correct Answer: Similarity of hydrodynamics and media composition to the physiological environment

Q15. In a multilayer reservoir tablet designed for pulsatile release, how is the delayed burst achieved?

• By immediate dissolution of the outermost layer
• By using a timed-release coating that ruptures or dissolves after a preset period
• By reducing core drug solubility to zero
• By eliminating any membrane around the core

Correct Answer: By using a timed-release coating that ruptures or dissolves after a preset period

Q16. For a hydrophilic matrix tablet that swells upon contact with fluid, which phenomenon contributes to controlled release?

• Formation of a gel layer that controls diffusion and erosion
• Immediate complete dissolution of the tablet
• Crystallization of drug at the surface only
• Increase in tablet density preventing fluid ingress

Correct Answer: Formation of a gel layer that controls diffusion and erosion

Q17. Which analytical parameter is most informative to compare release rates between two membrane-controlled formulations of the same drug?

• Initial burst release only
• Steady-state flux (Jss) and permeability coefficient
• Color of the formulation
• Total mass of tablet without release data

Correct Answer: Steady-state flux (Jss) and permeability coefficient

Q18. When designing a rate-controlled system for a highly water-soluble drug, which strategy helps avoid an initial burst release?

• Use of highly porous hydrophilic matrix only
• Incorporation into a less permeable or crosslinked polymer matrix or use of reservoir with membrane
• Loading the highest possible drug concentration without modification
• Eliminating any membrane or polymer to encourage rapid delivery

Correct Answer: Incorporation into a less permeable or crosslinked polymer matrix or use of reservoir with membrane

Q19. Which experimental observation indicates erosion-controlled release from a biodegradable polymer implant?

• Release rate independent of polymer mass loss
• Correlation between polymer mass loss and cumulative drug released
• Drug release following square-root time dependence strictly
• No change in polymer molecular weight over time

Correct Answer: Correlation between polymer mass loss and cumulative drug released

Q20. In designing a long-acting injectable microsphere system, which factor most directly affects the initial burst followed by sustained release?

• Particle size distribution, surface-associated drug, and polymer degradation profile
• Color of the injectable suspension
• Temperature of storage only if below freezing
• Use of non-biodegradable salts in the formulation only

Correct Answer: Particle size distribution, surface-associated drug, and polymer degradation profile

Download